Short Interest in AnPac Bio-Medical Science Co., Ltd. (NASDAQ:ANPC) Decreases By 95.8%

AnPac Bio-Medical Science Co., Ltd. (NASDAQ:ANPCGet Rating) saw a significant drop in short interest during the month of October. As of October 31st, there was short interest totalling 21,800 shares, a drop of 95.8% from the October 15th total of 518,900 shares. Based on an average trading volume of 177,500 shares, the days-to-cover ratio is currently 0.1 days.

AnPac Bio-Medical Science Stock Up 0.3 %

Shares of ANPC opened at $3.85 on Friday. The stock has a 50 day moving average of $3.71 and a 200 day moving average of $5.05. AnPac Bio-Medical Science has a 12 month low of $2.60 and a 12 month high of $38.40.

Hedge Funds Weigh In On AnPac Bio-Medical Science

A hedge fund recently raised its stake in AnPac Bio-Medical Science stock. Virtu Financial LLC raised its position in shares of AnPac Bio-Medical Science Co., Ltd. (NASDAQ:ANPCGet Rating) by 206.0% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 106,138 shares of the company’s stock after purchasing an additional 71,447 shares during the period. Virtu Financial LLC owned approximately 0.72% of AnPac Bio-Medical Science worth $47,000 at the end of the most recent reporting period. 2.66% of the stock is currently owned by institutional investors and hedge funds.

About AnPac Bio-Medical Science

(Get Rating)

AnPac Bio-Medical Science Co, Ltd., a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People's Republic of China. It also offers physical checkup package services.

Further Reading

Receive News & Ratings for AnPac Bio-Medical Science Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AnPac Bio-Medical Science and related companies with MarketBeat.com's FREE daily email newsletter.